|
See related Entocort cap information |
|
|
|
Manufacturer |
AstraZeneca |
|
Distributor |
Hong Kong: Zuellig/Macau: Four Star |
|
Contents |
Budesonide |
|
Indications |
Mild to moderate Crohn's disease affecting the ileum &/or ascending colon.
Click to view Entocort Cap detailed prescribing infomation |
|
Dosage |
Adjust dosage depending on the activity of the disease. Active Crohn's disease 9 mg (3 cap) daily for 8 wk. Remission 6 mg (2 cap).
Click to view Entocort Cap detailed prescribing infomation |
|
Overdosage |
View Entocort Cap overdosage for action to be taken in the event of an overdose. |
|
Administration |
Should be taken with food (Take in the morning. Swallow whole, do not crush/chew. Avoid grapefruit juice.). |
|
Contraindications |
Bacterial, fungal or viral infections.
Click to view Entocort Cap detailed prescribing infomation |
|
Special Precautions |
TB, HTN, diabetes mellitus, osteoporosis, peptic ulcer, newly created anastomoses, psychoses, cardiac insufficiency, glaucoma or cataracts, patients w/ a family history of diabetes or glaucoma. Treatment of growing individuals. Discontinuation should be gradual. Pregnancy. Avoid co-administration w/ ketoconazole & grapefruit.
Click to view Entocort Cap detailed prescribing infomation |
|
Adverse Drug Reactions |
Dyspepsia, palpitation, nervousness, inhibition of endogenous ACTH & cortisol secretion, Cushing-like symptoms, dyspepsia, rash, urticaria, muscular cramps, tremor, reduced visual acuity, inhibition of defense against infection, menstrual disturbances.
View ADR Monitoring Form |
|
Drug Interactions |
Ketoconazole, grapefruit juice, cimetidine.
View more drug interactions with Entocort Cap |
|
Pregnancy Category (US FDA) |
Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus. |
|
Storage |
View Entocort Cap storage conditions for details to ensure optimal shelf-life. |
|
Description |
View Entocort Cap description for details of the chemical structure and excipients (inactive components). |
|
Mechanism of Action |
View Entocort Cap mechanism of action for pharmacodynamics and pharmacokinetics details. |
|
Presentation/Packing |
|
Form |
Packing |
Photo |
|
Entocort Cap capsule |
|
Entocort Cap 3 mg x 50's |
 |
|
|
|
Manufacturer: |
AstraZeneca |
|
Distributor: |
Hong Kong: Zuellig
Macau: Four Star
|
|
|
|
